Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.662
-0.005 (-0.72%)
At close: Dec 5, 2025, 4:00 PM EST
0.663
+0.001 (0.12%)
After-hours: Dec 5, 2025, 5:34 PM EST
Rallybio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 0.67 | 0.64 | - | - | - | - | |
| Cost of Revenue | 39.03 | 39.51 | 53.54 | - | - | - | |
| Gross Profit | -38.36 | -38.87 | -53.54 | - | - | - | |
| Selling, General & Admin | 13.81 | 18.33 | 25.39 | 27.2 | 18.74 | 7.67 | |
| Research & Development | -18.9 | - | - | 40.69 | 26.91 | 17.63 | |
| Operating Expenses | -5.1 | 18.33 | 25.39 | 67.88 | 45.65 | 25.3 | |
| Operating Income | -33.26 | -57.2 | -78.93 | -67.88 | -45.65 | -25.3 | |
| Interest Expense | - | - | - | - | -0.01 | -0.05 | |
| Interest & Investment Income | 2.44 | 4.22 | 6.15 | 1.96 | 0.05 | 0.17 | |
| Earnings From Equity Investments | -1.3 | -2.24 | -2.04 | -1.08 | -1.51 | -1.52 | |
| Other Non Operating Income (Expenses) | 0.74 | 0.74 | 0.26 | 0.34 | 0.1 | 0.24 | |
| EBT Excluding Unusual Items | -31.38 | -54.48 | -74.56 | -66.65 | -47.01 | -26.46 | |
| Merger & Restructuring Charges | -5 | -3.3 | - | - | - | - | |
| Pretax Income | -14.17 | -57.78 | -74.56 | -66.65 | -47.01 | -26.46 | |
| Income Tax Expense | - | - | - | - | - | -0.02 | |
| Net Income | -14.17 | -57.78 | -74.56 | -66.65 | -47.01 | -26.45 | |
| Net Income to Common | -14.17 | -57.78 | -74.56 | -66.65 | -47.01 | -26.45 | |
| Shares Outstanding (Basic) | 45 | 44 | 40 | 32 | 26 | 17 | |
| Shares Outstanding (Diluted) | 45 | 44 | 40 | 32 | 26 | 17 | |
| Shares Change (YoY) | 5.40% | 7.66% | 27.11% | 24.70% | 46.76% | 913.79% | |
| EPS (Basic) | -0.32 | -1.33 | -1.84 | -2.09 | -1.84 | -1.52 | |
| EPS (Diluted) | -0.32 | -1.33 | -1.84 | -2.09 | -1.84 | -1.52 | |
| Free Cash Flow | -35 | -49.28 | -60.28 | -57.34 | -45.87 | -22.18 | |
| Free Cash Flow Per Share | -0.78 | -1.13 | -1.49 | -1.80 | -1.80 | -1.27 | |
| Operating Margin | -4934.72% | -8993.08% | - | - | - | - | |
| Profit Margin | -2102.37% | -9084.12% | - | - | - | - | |
| Free Cash Flow Margin | -5192.28% | -7748.74% | - | - | - | - | |
| EBITDA | -33.14 | -57.07 | -78.78 | -67.72 | -45.54 | -25.24 | |
| D&A For EBITDA | 0.12 | 0.13 | 0.15 | 0.17 | 0.11 | 0.06 | |
| EBIT | -33.26 | -57.2 | -78.93 | -67.88 | -45.65 | -25.3 | |
| Revenue as Reported | 0.67 | 0.64 | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.